SCHEMBL16181564

SCHEMBL16181564

CC1=C(C(=O)OC(c2ccccc2)c2ccccc2)N2C(=O)[C@@H](NC(=O)/C(=N\OC(c3ccccc3)(c3ccccc3)c3ccccc3)c3nsc(N)n3)[C@H]2SC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 4/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ MAPT P10636 3/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ SLC15A2 Q16348 2/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ BLM P54132 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ ADRA1A P35348 1/20 0.46
▸ HTR2B P41595 1/20 0.46
▸ KCNH2 Q12809 1/20 0.45
▸ PTGS1 P23219 2/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ NR1I2 O75469 3/20 0.40
▸ ESR1 P03372 2/20 0.40
▸ PPARG P37231 2/20 0.40
▸ PGR P06401 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14773851 0.91 KCNH2 (0.43) HSD17B10ALDH1A1KMT2AMAPTMAPK1
SCHEMBL1947682 0.91 KCNH2 (0.43) HSD17B10ALDH1A1KMT2AMAPTMAPK1
SCHEMBL2595984 0.91 KCNH2 (0.43) HSD17B10ALDH1A1KMT2AMAPTMAPK1
SCHEMBL14773850 0.91 KCNH2 (0.44) HSD17B10ALDH1A1KMT2AMAPTTDP1
SCHEMBL2595316 0.91 KCNH2 (0.44) HSD17B10ALDH1A1KMT2AMAPTTDP1
SCHEMBL2595314 0.91 KCNH2 (0.44) HSD17B10ALDH1A1KMT2AMAPTTDP1
SCHEMBL6542731 0.90 KCNH2 (0.43) HSD17B10ALDH1A1KMT2AMAPTMAPK1
SCHEMBL7225657 0.90 KCNH2 (0.43) HSD17B10ALDH1A1KMT2AMAPTMAPK1
SCHEMBL7225660 0.90 KCNH2 (0.43) HSD17B10ALDH1A1KMT2AMAPTMAPK1
SCHEMBL6542726 0.90 KCNH2 (0.43) HSD17B10ALDH1A1KMT2AMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8865697-B2 Crystalline (6R,7R)-7-{2-(5-amino-[1,2,4] thiadiazol-3-yl)-2-[(Z)-trityloxyimino]-acetylamino}-3-[(R)-1′-tert-butoxycarbonyl-2-oxo-[1,3′]bipyrrolidinyl-(3E)-ylidenemethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester; its manufacture and use BASILEA PHARMACEUTICA AG (CH) 2014-10-21 — — US disclosed
Send feedback